Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LBP Antikörper

LBP Reaktivität: Maus ELISA Wirt: Maus Monoclonal biG35 unconjugated
Produktnummer ABIN343174
  • Target Alle LBP Antikörper anzeigen
    LBP (Lipopolysaccharide Binding Protein (LBP))
    Reaktivität
    • 40
    • 18
    • 17
    • 9
    • 8
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    Maus
    Wirt
    • 46
    • 17
    • 5
    • 2
    Maus
    Klonalität
    • 48
    • 22
    Monoklonal
    Konjugat
    • 56
    • 7
    • 3
    • 3
    • 1
    Dieser LBP Antikörper ist unkonjugiert
    Applikation
    • 47
    • 26
    • 24
    • 17
    • 10
    • 9
    • 8
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA
    Spezifität
    Mouse LBP. The antibody don't blocks LPS binding to membrane bound CD14.
    Kreuzreaktivität
    Ratte (Rattus)
    Aufreinigung
    Protein A affinity column
    Immunogen
    native mouse LBP
    Klon
    BiG35
    Isotyp
    IgG2a
    Top Product
    Discover our top product LBP Primärantikörper
  • Applikationshinweise
    ELISA, LBP inhibition studies, Western Blot. Non inhibition of LPS binding to membrane bound CD14, Binding titre at - ELISA: more than1:20.000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Reconstitute with bidistilled water
    Konzentration
    1 mg/mL
    Buffer
    PBS, pH 7.18
    Konservierungsmittel
    Without preservative
    Lagerung
    -20 °C,-80 °C
  • Stamme, Mueller, Hamann, Gutsmann, Seydel: "Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein." in: American journal of respiratory cell and molecular biology, Vol. 27, Issue 3, pp. 353-60, (2002) (PubMed).

    Gutsmann, Mueller, Carroll, MacKenzie, Wiese, Seydel: "Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells." in: Infection and immunity, Vol. 69, Issue 11, pp. 6942-50, (2001) (PubMed).

    Hamann, Schumann, Flad, Brade, Rietschel, Ulmer: "Binding of lipopolysaccharide (LPS) to CHO cells does not correlate with LPS-induced NF-kappaB activation." in: European journal of immunology, Vol. 30, Issue 1, pp. 211-6, (2000) (PubMed).

  • Target
    LBP (Lipopolysaccharide Binding Protein (LBP))
    Andere Bezeichnung
    Lipopolysaccharide (LPS)-Binding Protein (LBP) (LBP Produkte)
    Synonyme
    BPIFD2 antikoerper, Bpifd2 antikoerper, Ly88 antikoerper, LPSBP antikoerper, LBP antikoerper, lipopolysaccharide binding protein antikoerper, lipopolysaccharide-binding protein antikoerper, LBP antikoerper, Lbp antikoerper, LOC100472839 antikoerper
    Hintergrund
    Background: Natural Lipopolysccaride Binding Protein (LBP) is a 58KD glycoprotein produced in liver. It binds at lipid A of LPS with high affinity (10-9M) and reduced the cellular LPS effects at CD14+ cells (IL1ß, IL6, TNFα). It acts as opsonin for GRAM negative cells, LPS, neutrophiles and granulocytes.
    Molekulargewicht
    ~58kDa
    Gen-ID
    16803
    UniProt
    Q61805
    Pathways
    TLR Signalweg, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, Toll-Like Receptors Cascades, Monocarboxylic Acid Catabolic Process
Sie sind hier:
Kundenservice